CD133-positive cells are resistant to TRAIL due to up-regulation of FLIP (2008)
Zobalova, Renata, McDermott, Laura Fay, Stantic, Marina, Prokopova, Katerina, Dong, Lan-feng, Neuzil, Jiri
CD133-positive cells are resistant to TRAIL due to up-regulation of FLIP (2008)
Zobalova, Renata, McDermott, Laura Fay, Stantic, Marina, Prokopova, Katerina, Dong, Lan-feng, Neuzil, Jiri
Yes
CD133-positive cells are resistant to TRAIL due to up-regulation of FLIP (2008)
Zobalova, Renata, McDermott, Laura Fay, Stantic, Marina, Prokopova, Katerina, Dong, Lan-feng, Neuzil, Jiri
Wang, Xiufang, Birringer, Marc, Dong, Lan-feng, Veprek, Pavel, Low, Pauline, Cowie, Emma Angela, ...
Overexpression of erbB2 is associated with resistance to apoptosis. We explored whether high level of erbB2 expression by cancer cells allows their targeting using an erbB2-binding peptide (LTVSPWY)...
Tumour-initiating cells vs. cancer 'stem' cells and CD133: What's in the name? (2007)
Neuzil, Jiri, Stantic, Marina, Zobalova, Renata, Chladova, Jaromira, Wang, Xiufang, Prochazka, Lubomir, ...
Recent evidence suggests that a subset of cells within a tumour have 'stem-like' characteristics. These tumour-initiating cells, distinct from non-malignant stem cells, show low proliferative rates,...
Dong, Lan-feng, Cowie, Emma Angela, Eliasson, Johanna Maria, Wang, Xiufang, Gold, Mikhal, Medunic, Yasmine, ...
''Mitocans'' from the vitamin E group of selective anticancer drugs, A-tocopheryl succinate (A-TOS) and its ether analogue A-TEA, triggered apoptosis in proliferating but not arrested endothelial...
Wang, Xiufang, Birringer, Marc, Dong, Lan-feng, Veprek, Pavel, Low, Pauline, Cowie, Emma Angela, ...
Overexpression of erbB2 is associated with resistance to apoptosis. We explored whether high level of erbB2 expression by cancer cells allows their targeting using an erbB2-binding peptide (LTVSPWY)...
Tumour-initiating cells vs. cancer 'stem' cells and CD133: What's in the name? (2007)
Neuzil, Jiri, Stantic, Marina, Zobalova, Renata, Chladova, Jaromira, Wang, Xiufang, Prochazka, Lubomir, ...
Recent evidence suggests that a subset of cells within a tumour have 'stem-like' characteristics. These tumour-initiating cells, distinct from non-malignant stem cells, show low proliferative rates,...
Dong, Lan-feng, Cowie, Emma Angela, Eliasson, Johanna Maria, Wang, Xiufang, Gold, Mikhal, Medunic, Yasmine, ...
Tumour-initiating cells vs. cancer 'stem' cells and CD133: What's in the name? (2007)
Neuzil, Jiri, Stantic, Marina, Zobalova, Renata, Chladova, Jaromira, Wang, Xiufang, Prochazka, Lubomir, ...
Recent evidence suggests that a subset of cells within a tumour have 'stem-like' characteristics. These tumour-initiating cells, distinct from non-malignant stem cells, show low proliferative rates,...
Dong, Lan-feng, Cowie, Emma Angela, Eliasson, Johanna Maria, Wang, Xiufang, Gold, Mikhal, Medunic, Yasmine, ...
''Mitocans'' from the vitamin E group of selective anticancer drugs, A-tocopheryl succinate (A-TOS) and its ether analogue A-TEA, triggered apoptosis in proliferating but not arrested endothelial...
Wang, Xiufang, Birringer, Marc, Dong, Lan-feng, Veprek, Pavel, Low, Pauline, Cowie, Emma Angela, ...
Overexpression of erbB2 is associated with resistance to apoptosis. We explored whether high level of erbB2 expression by cancer cells allows their targeting using an erbB2-binding peptide (LTVSPWY)...
Tumour-initiating cells vs. cancer 'stem' cells and CD133: What's in the name? (2007)
Neuzil, Jiri, Stantic, Marina, Zobalova, Renata, Chladova, Jaromira, Wang, Xiufang, Prochazka, Lubomir, ...
Recent evidence suggests that a subset of cells within a tumour have 'stem-like' characteristics. These tumour-initiating cells, distinct from non-malignant stem cells, show low proliferative rates,...
Dong, Lan-feng, Cowie, Emma Angela, Eliasson, Johanna Maria, Wang, Xiufang, Gold, Mikhal, Medunic, Yasmine, ...
''Mitocans'' from the vitamin E group of selective anticancer drugs, A-tocopheryl succinate (A-TOS) and its ether analogue A-TEA, triggered apoptosis in proliferating but not arrested endothelial...